Iopamidol Bracco Imaging 150 mg/ml inj. sol. i.v./i.thec./i.arter. vial Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

iopamidol bracco imaging 150 mg/ml inj. sol. i.v./i.thec./i.arter. vial

bracco imaging s.p.a. - iopamidol 306,2 mg/ml - eq. iodine 150 mg/ml - solution for injection - 150 mg/ml - iopamidol 306.2 mg/ml - iopamidol

Iopamidol Bracco Imaging 200 mg/ml inj. sol. i.v./i.thec./i.arter. amp. Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

iopamidol bracco imaging 200 mg/ml inj. sol. i.v./i.thec./i.arter. amp.

bracco imaging s.p.a. - iopamidol 408,2 mg/ml - eq. iodine 200 mg/ml - solution for injection - 200 mg/ml - iopamidol 408.2 mg/ml - iopamidol

Iopamidol Bracco Imaging 370 mg/ml inj. sol. i.v./i.thec./i.arter. vial Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

iopamidol bracco imaging 370 mg/ml inj. sol. i.v./i.thec./i.arter. vial

bracco imaging s.p.a. - iopamidol 755,3 mg/ml - eq. iodine 370 mg/ml - solution for injection - 370 mg/ml - iopamidol 755.3 mg/ml - iopamidol

Iopamidol Bracco Imaging 300 mg/ml inj. sol. i.v./i.thec./i.arter. amp. Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

iopamidol bracco imaging 300 mg/ml inj. sol. i.v./i.thec./i.arter. amp.

bracco imaging s.p.a. - iopamidol 612,4 mg/ml - eq. iodine 300 mg/ml - solution for injection - 300 mg/ml - iopamidol 612.4 mg/ml - iopamidol

Iopamidol Bracco Imaging 300 mg/ml inj. sol. i.v./i.thec./i.arter. vial Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

iopamidol bracco imaging 300 mg/ml inj. sol. i.v./i.thec./i.arter. vial

bracco imaging s.p.a. - iopamidol 612,4 mg/ml - eq. iodine 300 mg/ml - solution for injection - 300 mg/ml - iopamidol 612.4 mg/ml - iopamidol

Iopamidol Bracco Imaging 370 mg/ml inj. sol. i.v./i.arter./i.thec. amp. Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

iopamidol bracco imaging 370 mg/ml inj. sol. i.v./i.arter./i.thec. amp.

bracco imaging s.p.a. - iopamidol 755,3 mg/ml - eq. iodine 370 mg/ml - solution for injection - 370 mg/ml - iopamidol 755.3 mg/ml - iopamidol

IOPAMIDOL injection, solution Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

iopamidol injection, solution

slate run pharmaceuticals - iopamidol (unii: jr13w81h44) (iopamidol - unii:jr13w81h44) - iopamidol injection is indicated for intrathecal administration in adult neuroradiology including myelography (lumbar, thoracic, cervical, total columnar), and for contrast enhancement of computed tomographic (cect) cisternography and ventriculography. iopamidol injection, 41% is indicated for thoraco-lumbar myelography in children over the age of two years. intrathecal administration of corticosteroids with iopamidol is contraindicated. because of overdosage considerations, immediate repeat myelography in the event of technical failure is contraindicated (see interval recommendation under dosage and administration). myelography should not be performed in the presence of significant local or systemic infection where bacteremia is likely.

IOPAMIDOL injection, solution Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

iopamidol injection, solution

slate run pharmaceuticals, llc - iopamidol (unii: jr13w81h44) (iopamidol - unii:jr13w81h44) - iopamidol injection is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, coronary arteriography and ventriculography, pediatric angiocardiography, selective visceral arteriography and aortography, peripheral venography (phlebography), and adult and pediatric intravenous excretory urography and intravenous adult and pediatric contrast enhancement of computed tomographic (cect) head and body imaging (see below). iopamidol injection may be used to refine diagnostic precision in areas of the brain which may not otherwise have been satisfactorily visualized. iopamidol injection may be useful to investigate the presence and extent of certain malignancies such as: gliomas including malignant gliomas, glioblastomas, astrocytomas, oligodendrogliomas and gangliomas, ependymomas, medulloblastomas, meningiomas, neuromas, pinealomas, pituitary adenomas, craniopharyngiomas, germinomas, and metastatic lesions. the usefulness of contrast enhancement for the inves

IOPAMIDOL INJECTION USP SOLUTION Καναδάς - Αγγλικά - Health Canada

iopamidol injection usp solution

hospira healthcare ulc - iopamidol - solution - 61% - iopamidol 61% - roentgenography

IOPAMIDOL INJECTION USP SOLUTION Καναδάς - Αγγλικά - Health Canada

iopamidol injection usp solution

hospira healthcare ulc - iopamidol - solution - 76% - iopamidol 76% - roentgenography